Tafenoquine in Patients With Mild to Moderate COVID-19

Clinical trial NCT04533347 · COMPLETED

Trial details

NCT number: NCT04533347
Sponsor: 60 Degrees Pharmaceuticals LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID 19 Disease

Start date: 2021-02-19
Primary completion: 2022-06-30
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.